Mirikizumab shows early and sustained efficacy in reducing bowel urgency and achieving remission in patients with moderate-to ...

Colon cancer is a leading yet preventable cause of cancer deaths. Screening, especially colonoscopy, is crucial for early ...

With colorectal cancer on the rise in people under 50, researchers at the University of Illinois Urbana-Champaign are looking at the colon's tiniest ...

Ozgul Coban had been in the job for just eight weeks when Alper Ozcelyan messaged her to say he needed 'continuity' in the ...

Avobis Bio LLC, a clinical stage company developing implantable cell therapies, announced today that primary analysis of the ...

Ozgul Coban had been in the job for just eight weeks when Alper Ozcelyan messaged her to say he needed 'continuity' in the ...

Sara Levitt and her life-saving ostomy bag are front and centre at the 2025 Miss Universe Canada pageant. On Aug. 9, the ...

More than half of adults with inflammatory bowel disease have at least one psychiatric comorbidity, according to research ...

A bodybuilder who was told he might die before he turned 40 after his bowel cancer was missed has said the screening age for ...

There is limited evidence to support the use of tumor necrosis factor-alpha antagonists (anti-TNF) therapy for induction of remission in children with Crohn's disease. • More well-designed studies are ...

Takeda Pharmaceutical Company saw its drug Entyvio (vedolizumab) approved in China by the National Medical Products ...

A new Crohn’s treatment that involves guselkumab showed outstandingly greater rates of endoscopic improvement, which are vital for reducing long-term complications.